← All trials
NCT04313400
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2020
- Primary completion
- Jan 3, 2021
- Completion date
- Jan 3, 2021
- First posted
- Mar 18, 2020
- Last posted
- Mar 18, 2020
- Enrollment
- 145
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Amytrx Therapeutics, Inc.Lead sponsor
- Amarex Clinical ResearchCollaborator
- Amarex Clinical ResearchStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.